Published in Clin Exp Immunol on June 01, 1987
Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease. BMJ (1990) 1.01
The interleukins in acquired disease. Clin Exp Immunol (1988) 0.96
Chicken pox infection (varicella zoster virus) and acute monoarthritis: evidence against a direct viral mechanism. J Clin Pathol (1992) 0.75
Defective cell mediated immunity in sarcoidosis: effect of interleukin-2. Thorax (1988) 0.75
Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol (1981) 9.86
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med (1982) 8.74
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 8.21
Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science (1984) 3.08
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (1987) 2.31
Interleukin 2 dependence of human natural killer (NK) cell activity. J Immunol (1983) 1.79
Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J Exp Med (1982) 1.76
Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature (1982) 1.75
The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis (1983) 1.61
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci U S A (1985) 1.53
In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice. Infect Immun (1984) 1.44
Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol (1981) 1.44
A diet enriched in vitamin A acetate or in vivo administration of interleukin-2 can counteract a tolerogenic stimulus. Proc R Soc Lond B Biol Sci (1984) 1.22
Characterization of human interleukin 2 derived from Escherichia coli. Biochem J (1985) 1.19
Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis (1984) 1.16
Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci U S A (1983) 1.10
Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF. Clin Immunol Immunopathol (1983) 1.08
Characterization of the killer cell generated in the autologous mixed leukocyte reaction. J Exp Med (1983) 1.02
Studies of rheumatoid synovial fluid lymphocytes. I. Evidence for activated natural killer- (NK) like cells. J Immunol (1982) 1.01
Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis. Arthritis Rheum (1981) 0.97
Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects. Ann Rheum Dis (1985) 0.93
Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis. Arthritis Rheum (1984) 0.91
Reduced expression of interleukin-2 receptors in hypogammaglobulinaemia: a possible cause of higher cancer incidence. Lancet (1986) 0.90
Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis. Arthritis Rheum (1985) 0.89
Human urinary bladder carcinoma cell line (T24): immunological studies and search for oncornavirus in T24 cell population and derived clones. Neoplasma (1978) 0.84
The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2. Semin Oncol (1986) 0.84
Total lymphoid irradiation in tertiary care for rheumatoid arthritis. Ann Intern Med (1985) 0.83
Autologous lymphoid cells exposed to recombinant interleukin-2 in vitro in the absence of antigen can induce the rejection of long-term tolerated skin allografts. Immunology (1986) 0.83
Impaired killer cell generation in the autologous mixed leukocyte reaction by rheumatoid arthritis lymphocytes. Arthritis Rheum (1985) 0.82
Impaired lymphokine-activated killer-cell activity in patients with hypogammaglobulinaemia. Lancet (1985) 0.79
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Variable and conserved neutralization antigens of human immunodeficiency virus. Nature (1987) 5.29
Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 5.11
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med (1993) 4.58
Epitopes of the CD4 antigen and HIV infection. Science (1986) 4.50
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma. J Clin Oncol (2004) 3.37
HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol (1977) 2.62
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut (1982) 2.37
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (1987) 2.31
Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology (1987) 2.30
Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26
AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today (1990) 2.21
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. BJU Int (1999) 2.14
Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell (1992) 2.13
Hypogammaglobulinaemia associated with gold therapy. Ann Rheum Dis (1984) 2.10
Soviet-style psychiatry is alive and well in the People's Republic. Br J Psychiatry (2001) 2.04
Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM. J Clin Pathol (1983) 2.04
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis (2001) 2.02
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain (1989) 2.00
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol (1990) 1.88
Human T cell leukaemia/lymphoma virus and blood donation. BMJ (1993) 1.79
Surgery and anesthesia in Ontario. Can Med Assoc J (1977) 1.77
Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment. Br Med J (1976) 1.75
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer (2013) 1.68
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Dichotomy between immunoglobulin synthesis by cells in gut and blood of patients with hypogammaglobulinaemia. Lancet (1975) 1.60
The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. BJOG (2010) 1.59
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev (1990) 1.56
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Coeliac disease with severe hypogammaglobulinaemia. Gut (1981) 1.55
Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes. Clin Exp Immunol (1976) 1.53
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci U S A (1985) 1.53
Identification and function of T cells in the peripheral blood of patients with hypogammaglobulinaemia. Clin Exp Immunol (1974) 1.53
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood (1996) 1.52
Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem (1997) 1.52
Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet (1977) 1.52
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Accelerometers in rehabilitation medicine for older adults. Age Ageing (2005) 1.49
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet (1984) 1.49
Common variable immunodeficiency: how many diseases? Immunol Today (1997) 1.48
Escherichia coli antibody: a screening test for immunodeficiency. Br Med J (1974) 1.46
Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia. Clin Exp Immunol (1980) 1.45
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. BMJ (1990) 1.45
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer (2002) 1.44
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer (2000) 1.43
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. Br J Cancer (2004) 1.43
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42
A description of an accelerometer-based mobility monitoring technique. Med Eng Phys (2005) 1.42
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? Ann Oncol (2010) 1.41
Behavioural management of aggression in dementia: a randomized controlled trial. Age Ageing (2001) 1.41
Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants. Clin Exp Allergy (1994) 1.41
Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation. Clin Oncol (R Coll Radiol) (1995) 1.41
The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens. AIDS (1995) 1.38
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer (2011) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
The role of de novo purine synthesis in lymphocyte transformation. Ciba Found Symp (1977) 1.37
Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity (2001) 1.36
Microhemangiomas at the pupillary border demonstrated by fluorescein photography. Am J Ophthalmol (1969) 1.36
Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol (1990) 1.35
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. Br J Cancer (2009) 1.35
Primary late-onset hypogammaglobulinaemia associated with inflammatory polyarthritis and septic arthritis due to Mycoplasma pneumoniae. Ann Rheum Dis (1983) 1.34
Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia. Clin Exp Immunol (1978) 1.33
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32
Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. Clin Exp Immunol (1989) 1.32
Inactivation of HIV by nonoxynol-9. Lancet (1988) 1.30
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells. Clin Exp Immunol (2002) 1.30
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ (2004) 1.28
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet (1981) 1.27
Two immunologically distinct forms of late-onset hypogammaglobulinaemia. Clin Exp Immunol (1981) 1.27
The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res (1996) 1.26
Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis (1994) 1.26
HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet (1985) 1.25
Encephalomyelitis in primary hypogammaglobulinaemia. Brain (1996) 1.25
Arthritis caused by Mycoplasma salivarium in hypogammaglobulinaemia. Br Med J (Clin Res Ed) (1983) 1.25